Natriuretic peptides and valvular heart disease
Yasumura, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 93-94
2004
ISSN/ISBN: 0047-1852 PMID: 15506345 Document Number: 576642
Document emailed within 1 workday
Related Documents
Lichodziejewska, B. 1993: Management of patients with valvular heart disease and poor ventricular function. the Working Group on Valvular Heart Disease Kardiologia Polska 39(10): 316-317Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Minamino, N. 1991: Biochemistry of natriuretic peptides--brain natriuretic peptide and its related peptides Seikagaku. Journal of Japanese Biochemical Society 63(2): 94-119
Horii, M.; Saito, Y. 2004: Natriuretic peptides in patients with heart failure Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 84-87
Rehman, S.U.; Januzzi, J.L. 2008: Natriuretic peptides for guiding heart failure therapy Comprehensive Therapy 34(1): 32-40
Cerra, M.C.; Gattuso, A. 1995: Natriuretic peptides binding sites in the vertebrate heart Bollettino della Societa Italiana di Biologia Sperimentale 71(1-2): 41-60
Angelika Hammerer-Lercher; Puschendorf, B.; Mair, J. 2001: Cardiac Natriuretic Peptides: New Laboratory Parameters In Heart Failure Patients Clinical Laboratory 47(5-6): 265-277
Lindstedt, G.ör. 2006: Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure Lakartidningen 103(12): 930
Matsumoto, T.; Wada, A.; Tsutamoto, T.; Omura, T.; Yokohama, H.; Ohnishi, M.; Nakae, I.; Takahashi, M.; Kinoshita, M. 1999: Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure American Journal of Physiology 276(6): H1935-H1942
Song, J.-p.; Shen, B.; Liu, Z.-h.; Jiang, W.-p. 2003: The changes of plasma levels of brain natriuretic peptides in evaluation of treatment responses in chronic heart failure Zhonghua Nei Ke Za Zhi 42(5): 306-308
Chan, W.Y.; Hruby, V.J. 1988: Natriuretic action of neurohypophysial peptides: effects of agonists and antagonists and implication of natriuretic receptor Journal of Pharmacology and Experimental Therapeutics 246(2): 597-602
Rosa, V.E.E.; Lopes, A.S.S.A.; Accorsi, T.A.D.; Fernandes, J.R.C.; Spina, G.S.; Sampaio, R.O.; Bacal, F.; Tarasoutchi, F. 2015: Heart Transplant in Patients with Predominantly Rheumatic Valvular Heart Disease Journal of Heart Valve Disease 24(5): 629-634
Sukhum, P.; McBride, J.W.; Long, L.A.; Campion, B.C. 1980: Echocardiography of valvular heart disease: evaluation of heart murmurs Minnesota Medicine 63(12): 869-877
Kobalava, D.; Kotovskaya, Y.V.; Villevalde, S.V.; Moiseev, V.S. 2015: Perspectives for the Blockade of the Renin-angiotensin-aldesteron System and Modulation of Natriuretic Peptides System in the Treatment of Arterial Hypertension and Heart Failure Kardiologiia 55(6): 72-81
Savova, A.; Stoitchev, S.; Ovanesyan, H.; Finkov, B.; Belov, J. 1986: Coronary artery disease in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 73-75
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Domenech, B.; Pomar, J.é L.; Prat-González, S.; Vidal, B.ár.; López-Soto, A.; Castella, M.; Sitges, M. 2016: Valvular Heart Disease Epidemics Journal of Heart Valve Disease 25(1): 1-7
Michel, P.L.; Garbarz, E.; Messika-Zeitoun, D.; Roussin, I. 2000: The best of valvular heart disease in 1999 Archives des Maladies du Coeur et des Vaisseaux 93(1 Spec No): 97-102
Livi, U.; Caforio, A.L.; Grassi, G.; Boffa, G.M.; Barchitta, A.; Gambino, A.; Thiene, G.; Casarotto, D. 1995: Heart transplantation for end-stage valvular disease Transplantation Proceedings 27(1): 1305-1306
Spitzer, W.O. 1997: Valvular heart disease associated with fenfluramine-phentermine New England Journal of Medicine 337(24): 1774-1775; Author Reply 1775-1776